Baxdrostat
AstraZeneca
[]
baxdrostat is a highly selective aldosterone synthase inhibitor! it has been shown in a prior phase 2 trials to sbp. primary endpoint of #halo was change in mean and seated sbp after 8 weeks of rx. #acc2023
Internal Medicine Resident at UPenn | Feinberg School of Medicine '16 | Views are my own